Evidence map›Paper›PMID 39926084›Full record

ArticleJMA journal2025

Temporal Changes in HbA1c Levels after Sacubitril/Valsartan Initiation in a Real-world Japanese Cohort: REVIEW-HF Registry.

Yukihiro Watanabe, Yoshiaki Kubota, Takuya Nishino, Takahito Nasu, Shunsuke Ishii, Nobuyuki Kagiyama, Keisuke Kida, Wataru Fujimoto, Koshiro Kanaoka, Shingo Matsumoto

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in JMA journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yukihiro WatanabeDepartment of Cardiovascular Medicine, Nippon Medical School, Tokyo, Japan.
Yoshiaki KubotaDepartment of Cardiovascular Medicine, Nippon Medical School, Tokyo, Japan.
Takuya NishinoDepartment of Health Care Administration, Nippon Medical School, Tokyo, Japan.
Takahito NasuDivision of Cardiology, Department of Internal Medicine, Iwate Medical University, Iwate, Japan.
Shunsuke IshiiDepartment of Cardiovascular Medicine, Kitasato University School of Medicine, Kanagawa, Japan.
Nobuyuki KagiyamaDepartment of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Keisuke KidaDepartment of Pharmacology, St. Marianna University School of Medicine, Kanagawa, Japan.
Wataru FujimotoDepartment of Cardiology, Hyogo Prefectural Awaji Medicine Center, Hyogo, Japan.
Koshiro KanaokaDepartment of Medical and Health Information Management, National Cerebral and Cardiovascular Center, Osaka, Japan.
Shingo MatsumotoDivision of Cardiovascular Medicine, Department of Internal Medicine, Toho University Faculty of Medicine, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AsiaDiabetesGlycemic controlHeart failureSacubitril/valsartan

Identifiers

PMID39926084
PMCPMC11799734

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.